Caylon Napier, in Beattyville, KY - Emergency Medicine

Caylon Napier, is a Emergency Medicine - Emergency Medical Services physician based in Beattyville, Kentucky. Caylon Napier is licensed to practice in Kentucky (license number 065125840) and his current practice location is 76 Willard Ln, Beattyville, Kentucky. He can be reached at his office (for appointments etc.) via phone at (859) 533-3911.

NPI number for Caylon Napier is 1245705052 and his current mailing address is 10197 Highway 30 E, Jackson, Kentucky. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1245705052.

Contact Information

	Caylon Napier,
	76 Willard Ln, Beattyville, KY 41311
	(859) 533-3911
	Not Available

Physician's Profile

Full Name	Caylon Napier
Gender	Male
Speciality	Emergency Medicine - Emergency Medical Services
Location	76 Willard Ln, Beattyville, Kentucky
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1245705052
Provider Enumeration Date: 10/08/2018
Last Update Date: 10/08/2018

Medical Identifiers

Medical identifiers for Caylon Napier such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1245705052	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207PE0004X	Emergency Medicine - Emergency Medical Services	065125840 (Kentucky)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Caylon Napier is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Caylon Napier, 10197 Highway 30 E, Jackson, KY 41339-7935 Ph: () -	Caylon Napier, 76 Willard Ln, Beattyville, KY 41311 Ph: (859) 533-3911

News Archive

OpenAnesthesia shows phenomenal success, exponential growth

Since its launch in 2009, the open-access website OpenAnesthesia.org has developed into a popular and powerful tool for spreading up-to-date knowledge in anesthesiology, according to a special editorial in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

Potential of genomics in disease research yet to be realized

Over the past decade genomics has revolutionized our understanding of how microorganisms cause disease. However, genomic studies need to be extended to a more diverse array of microorganisms and research tools improved to gain additional insights into pathogenesis, according to a new report released by the American Academy of Microbiology.

Stroke-related deaths increased during the first lockdown

Deaths of people who suffered strokes increased during the first lockdown compared to the three previous years, new data analysis has found. Despite the pandemic, health care quality was maintained at a high level.

Generics as good as brand-name drugs when treating heart diseases

Contrary to the perception of some patients and physicians, there is no evidence that brand-name drugs are clinically superior to their generic counterparts, according to an article in the December 3 issue of JAMA, which examined studies comparing the effectiveness of generic vs. brand-name drugs for treating cardiovascular diseases.

Caylon Napier, - Emergency Medicine in Beattyville, KY